Skip to main content
. 2022 Sep 19;15:1979–1990. doi: 10.2147/CCID.S378106

Table 4.

Complications and Prognosis Related to Systemic Glucocorticoids

Types of Complications SJS (n,%) SJS/TEN (n,%) TEN (n,%) Case (n,%) Healed at Discharge (%) Better at Discharge (%) Not Getting Better at Discharge (%)
Infection 3 (18.8) 3 (37.5) 20 (62.5) 26 (46.4) 12 (46.2) 13 (50.1) 1 (3.8)
Secondary skin lesions 1 (6.2) 0 (0.0) 11 (34.4) 12 (21.4) 8 (66.7) 4 (33.3) 0
Thrush 2 (12.5) 1 (12.5) 7 (21.9) 10 (17.9) 3 (30.0) 7 (70.0) 0
Respiratory tract 0 (0.0) 1 (12.5) 5 (15.6) 6 (10.7) 3 (50.0) 3 (50.0) 0
Bacteremia 0 0 1 (3.1) 1 (1.8) 1 (100.0) 0 0
Peritonitis 0 0 1 (3.1) 1 (1.8) 0 0 1 (100.0)
Other infections 1 (6.2) 1 (12.5) 0 0 0 2 (100.0) 0
Steroid diabetes 1 (6.2) 0 (0.0) 4 (12.5) 5 (8.9) 1 (20.0) 4 (80.0) 0
Electrolyte 6 (37.5) 2 (25.0) 14 (43.8) 22 (39.3) 15 (68.2) 5 (22.7) 2 (9.1)
Low potassium 4 (25.0) 1 (12.5) 6 (18.8) 11 (19.6) 9 (81.8) 1 (9.1) 1 (9.1)
Low calcium 3 (18.8) 1 (12.5) 9 (28.1) 13 (23.2) 8 (61.5) 4 (30.8) 1 (7.7)
Liver damage 2 (12.5) 2 (25.0) 9 (28.1) 13 (23.2) 4 (30.8) 8 (61.5) 1 (7.7)
Thrombosis 0 0 1 (3.1) 1 (1.8) 0 1 (100.0) 0
Death 0 0 1 (3.1) 1 (1.8) 0 0 1
Total 9 (56.2) 4 (50.0) 28 (87.5) 41 (73.2) 11 (26.8) 27 (65.9) 3 (7.3)